Home
On-Demand
Industrie
FAQ
Home
On-Demand
Industrie
FAQ
Schlagwort
ATALANTE-Studie
Ovarialkarzinom – Systemtherapie
Ovarialkarzinom – Systemtherapie
Antiangiogenese
/
Ariel-4-Studie
/
ATALANTE-Studie
/
ATHENA–MONO-Studie
/
bevacizumab
/
Cediranib
/
Fuzuloparib
/
Gemcitabine
/
Immunonkologie
/
LGSOC
/
Nivolumab
/
Olaparib
/
Ovarialkarzinom
/
PARPi
/
Rucaparib
